Patricia Patterson

1.0k total citations
29 papers, 717 citations indexed

About

Patricia Patterson is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Patricia Patterson has authored 29 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Patricia Patterson's work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (9 papers) and HIV/AIDS Research and Interventions (8 papers). Patricia Patterson is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (9 papers) and HIV/AIDS Research and Interventions (8 papers). Patricia Patterson collaborates with scholars based in Argentina, United States and Mexico. Patricia Patterson's co-authors include Pedro Cahn, Michael E. Kimerling, Penny Phillips, Omar Sued, C. Andrew Robinson, Nancy E. Dunlap, María José Rolón, María Inés Figueroa, Susan M. Harding and Nancy Carney and has published in prestigious journals such as PLoS ONE, CHEST Journal and The Lancet Infectious Diseases.

In The Last Decade

Patricia Patterson

28 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Patterson Argentina 13 355 192 181 91 88 29 717
Erin Leister United States 16 237 0.7× 106 0.6× 110 0.6× 112 1.2× 24 0.3× 27 833
Andrea R. Levine United States 13 200 0.6× 86 0.4× 146 0.8× 67 0.7× 35 0.4× 37 676
Chris Corbett United Kingdom 14 73 0.2× 21 0.1× 235 1.3× 254 2.8× 71 0.8× 27 746
Sara E. Looby United States 18 233 0.7× 181 0.9× 128 0.7× 182 2.0× 82 0.9× 51 944
Janet Gulla United States 12 64 0.2× 67 0.3× 72 0.4× 125 1.4× 27 0.3× 17 564
David Condoluci United States 9 130 0.4× 76 0.4× 94 0.5× 35 0.4× 66 0.8× 15 349
Stefan Christensen Germany 20 226 0.6× 78 0.4× 449 2.5× 209 2.3× 21 0.2× 62 1.1k
Felice Su United States 14 112 0.3× 43 0.2× 94 0.5× 122 1.3× 29 0.3× 43 838
FI Ojini Nigeria 13 62 0.2× 60 0.3× 345 1.9× 29 0.3× 33 0.4× 38 667
Nathalie Maes Belgium 14 111 0.3× 44 0.2× 72 0.4× 28 0.3× 38 0.4× 48 578

Countries citing papers authored by Patricia Patterson

Since Specialization
Citations

This map shows the geographic impact of Patricia Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Patterson more than expected).

Fields of papers citing papers by Patricia Patterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Patterson. The network helps show where Patricia Patterson may publish in the future.

Co-authorship network of co-authors of Patricia Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Patterson. A scholar is included among the top collaborators of Patricia Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Patterson. Patricia Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arístegui, Inés, María Inés Figueroa, Carina César, et al.. (2023). Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV study. PLoS ONE. 18(1). e0279996–e0279996. 5 indexed citations
3.
Belaunzarán-Zamudio, Pablo F., Juan Sierra Madero, Jaime Andrade‐Villanueva, et al.. (2020). The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection. HIV Medicine. 22(4). 254–261. 3 indexed citations
4.
Cahn, Pedro, Valeria Fink, & Patricia Patterson. (2018). Fostemsavir. Current Opinion in HIV and AIDS. 13(4). 341–345. 26 indexed citations
5.
Caro‐Vega, Yanink, Pablo F. Belaunzarán-Zamudio, Brenda Crabtree‐Ramírez, et al.. (2018). Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: a growing challenge. Epidemiology and Infection. 146(10). 1308–1311. 12 indexed citations
7.
Ghiglione, Yanina, et al.. (2016). Modification of the HIV-specific CD8+ T-cell response in an HIV elite controller after chikungunya virus infection. AIDS. 30(12). 1905–1911. 4 indexed citations
8.
Patterson, Patricia, et al.. (2014). Switching to nevirapine‐based regimens after undetectable viral load is not associated with increased risk of discontinuation due to toxicity. Journal of the International AIDS Society. 17(4S3). 19794–19794. 1 indexed citations
9.
Cahn, Pedro, Jaime Andrade‐Villanueva, José Ramón Arribas, et al.. (2014). Changes in lipid levels after 48 weeks of dual versus triple therapy observed in the GARDEL study. Journal of the International AIDS Society. 17(4S3). 19554–19554. 3 indexed citations
11.
Edwards, Eric S., et al.. (2013). Design validation and labeling comprehension study for a new epinephrine autoinjector. Annals of Allergy Asthma & Immunology. 110(3). 189–193.e1. 10 indexed citations
12.
Patterson, Patricia, Omar Sued, Valeria Fink, et al.. (2012). A phase 4, single‐arm, open‐label, pilot study of maraviroc, raltegravir and darunavir/r in HIV‐1 adults with triple class failure: TERCETO study. Journal of the International AIDS Society. 15(S4). 1–1. 2 indexed citations
13.
Cahn, Pedro, Julio Montaner, Patricia Patterson, et al.. (2011). Pilot, Randomized Study Assessing Safety, Tolerability and Efficacy of Simplified LPV/r Maintenance Therapy in HIV Patients on the 1st PI-Based Regimen. PLoS ONE. 6(8). e23726–e23726. 16 indexed citations
14.
Carney, Nancy, et al.. (2005). Rehabilitation for Traumatic Brain Injury. PubMed Central. 62 indexed citations
15.
Guzzo, Melany R., et al.. (2002). Oral Corticosteroids Increase Esophageal Acid Contact Times in Patients With Stable Asthma. CHEST Journal. 121(2). 625–634. 58 indexed citations
16.
Patterson, Patricia & Susan M. Harding. (1999). Gastroesophageal reflux disorders and asthma. Current Opinion in Pulmonary Medicine. 5(1). 63–63. 25 indexed citations
17.
Patterson, Patricia & Michael Allon. (1998). Prospective evaluation of an anemia treatment algorithm in hemodialysis patients. American Journal of Kidney Diseases. 32(4). 635–641. 17 indexed citations
18.
Carney, Nancy, et al.. (1998). Rehabilitation for Traumatic Brain Injury: Summary. 2 indexed citations
19.
Kimerling, Michael E., et al.. (1998). Low Serum Antimycobacterial Drug Levels in Non-HIV-Infected Tuberculosis Patients. CHEST Journal. 113(5). 1178–1183. 136 indexed citations
20.
Patterson, Patricia, et al.. (1990). An Evaluation Device for Quantifying Joint Stiffness in the Burned Hand. Journal of Burn Care & Rehabilitation. 11(4). 312–317. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026